Deborah Neyrinck-Leglantier, Marie Tamagne, Raida Ben Rayana, Souganya Many, Paul Vingert, Julie LeGagneux, Adèle Silane Delorme, Muriel Andrieu, Eric Boilard, Fabrice Cognasse, Hind Hamzeh-Cognasse, Santiago Perez-Patrigeon, Jean-Daniel Lelievre, France Pirenne, Sébastien Gallien, Benoît Vingert
INTRODUCTION: People living with HIV (PLWH) now benefit from combined antiviral treatments that durably control viral replication. These antiretroviral treatments decrease mortality and improve quality of life in PLWH, but do not completely control the excessive non-specific activation of the immune system in PLWH. This chronic immune activation is a key element of HIV immunopathology that contributes to the pathophysiology of inflammatory comorbid conditions, such as cardiovascular disorders, cancer and autoimmune diseases...
2024: Frontiers in Immunology